Page 7 - ரோஸ்வெல் பூங்கா விரிவான புற்றுநோய் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study shows promise of combining radiation therapy with dendritic-cell vaccines for breast cancer A research team led by Fumito Ito, MD, PhD, FACS, of Roswell Park Comprehensive Cancer Center reports new data on the promise of combining standard treatment for breast cancer with a particular form of cancer immmunotherapy -; dendritic-cell (DC) treatment vaccines. This study, published in the Journal for ImmunoTherapy of Cancer, is the first to demonstrate that in situ dendritic-cell vaccines can improve the effectiveness of radiation therapy for some aggressive and treatment-resistant forms of breast cancer. Although immunotherapy with primary conventional dendritic cells is a promising approach, obtaining a sufficient number of circulating conventional dendritic cells has proved difficult, says Dr. Ito, who is Associate Professor of Surgical Oncology at Roswell Park. Use of induced pluripotent stem cells (iPSCs) has been proposed to overcome that limitation, but the feasibility

Fumito itoEmily hendersonRoswell park comprehensive cancer centerNature communicationsAssociate professorSurgical oncologyRoswell park comprehensive cancerஎமிலி ஹென்டர்சன்ரோஸ்வெல் பூங்கா விரிவான புற்றுநோய் மையம்இயற்கை தகவல்தொடர்புகள்இணை ப்ரொஃபெஸர்அறுவை சிகிச்சை புற்றுநோயியல்ரோஸ்வெல் பூங்கா விரிவான புற்றுநோய்